Latest filings (excl ownership)
15-12G
Securities registration termination
20 Jan 09
EFFECT
Notice of effectiveness
16 Jan 09
POS AM
Prospectus update (post-effective amendment)
16 Jan 09
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Jan 09
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Jan 09
S-8 POS
Registration of securities for employees (post-effective amendment)
16 Jan 09
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9 Jan 09
25-NSE
Exchange delisting
7 Jan 09
SC 14D9/A
Tender offer solicitation (amended)
7 Jan 09
SC TO-T/A
Third party tender offer statement (amended)
7 Jan 09
SC TO-T/A
Third party tender offer statement (amended)
30 Dec 08
SC TO-T/A
Third party tender offer statement (amended)
15 Dec 08
UPLOAD
Letter from SEC
9 Dec 08
SC TO-T/A
Third party tender offer statement (amended)
8 Dec 08
SC TO-T/A
Third party tender offer statement (amended)
3 Dec 08
SC TO-T/A
Third party tender offer statement (amended)
21 Nov 08
UPLOAD
Letter from SEC
21 Nov 08
SC14D9C
Written communication relating to third party tender offer
20 Nov 08
10-Q
2009 Q3
Quarterly report
13 Nov 08
8-K
Results of Operations and Financial Condition
13 Nov 08
SC 14D9
Tender offer solicitation
12 Nov 08
SC TO-T
Third party tender offer statement
12 Nov 08
8-K
Entry into a Material Definitive Agreement
3 Nov 08
SC TO-C
Information about tender offer
3 Nov 08
8-K/A
Departure of Directors or Principal Officers
30 Oct 08
SC TO-C
Information about tender offer
30 Oct 08
SC14D9C
Written communication relating to third party tender offer
30 Oct 08
8-K
Departure of Directors or Principal Officers
7 Oct 08
8-K
Departure of Directors or Principal Officers
4 Sep 08
10-Q
2009 Q2
Quarterly report
12 Aug 08
8-K
Results of Operations and Financial Condition
12 Aug 08
8-K
Changes in Registrant.s Certifying Accountant
10 Jul 08
8-K
Genelabs Provides Update on Hepatitis C Drug Development With Collaboration Partners
23 Jun 08
10-Q
2009 Q1
Quarterly report
14 May 08
8-K
Genelabs Reports Results for the First Quarter of 2008 and Progress on Operational Priorities
14 May 08
8-K
Genelabs Technologies, Inc. Receives Notification from NASDAQ Regarding Non-Compliance with NASDAQ’s Minimum Closing Bid Price Rule
25 Apr 08
DEF 14A
Definitive proxy
25 Apr 08
10-K
2007 FY
Annual report
31 Mar 08
Latest ownership filings
No filings